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Introduction
Perinatal transmission of HIV can occur in utero, during 
delivery and postpartum through breastfeeding. The risk 
of perinatal HIV transmission depends on factor such as 
maternal viral load, infant mode of delivery, the presence of 
other sexually transmitted infections, and duration of ruptured 
membranes.[1-3]
The risk of HIV transmission from an infected mother to a 
child varies from 15% to 30%.[4] This risk can be reduced 
to <2% with appropriate intervention using combination 
antiretroviral (ARV) therapy during pregnancy and labor, 
delivery through cesarean section for HIV-infected mothers 
with unknown viral load or viral load >1000 copies/ml and 
avoidance of breastfeeding among HIV-infected women.[3] This 
has resulted in a dramatic decline in the number of children 
with perinatal HIV infection from an estimated annual peak 
of 1650 infected infants in mid-1990s to 142 infants in 2005 
in the United States.[5-8] The framework for the elimination of 
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perinatal transmission of HIV starts with the early identification 
of pregnant women who are HIV-infected. Initially, the 
recommendation was targeted HIV screening of pregnant 
women, which was eventually changed to routine screening 
for all pregnant women in the United States.[9,10]
Nevada documented its highest cases of perinatally 
acquired HIV infection with eight confirmed cases in 1998 
and was identified by the Centers for Disease Control 
and Prevention (CDC) as the only state west of the Mississippi 
River with an increasing number of women of childbearing 
age living with HIV infection in 2004.[11,12] Although Nevada 
had the nation’s 35th largest population at the time, it ranked 
14th in the nation for the rate of adolescents/adults living with 
AIDS.[13] Six new cases of perinatally acquired HIV infections 
were documented in Clark County over a 9 months period from 
September 2005 to June 2006.[14] Clark County comprises the 
southern tip of Nevada and includes the cities of Las Vegas, 
Henderson, North Las Vegas and Boulder City.
The Department of Pediatrics at the University of 
Nevada-School of Medicine received a Community Access 
to Child Health (CATCH) grant from the American Academy 
of Pediatrics (AAP) to determine why children were still being 
infected with HIV in Clark County. The medical records of 
HIV-infected pregnant women who delivered an infant from 
July 2005 to June 2006 were reviewed, and common systemic 
barriers to prevention were identified.[15] Subsequently, funding 
from the Sawyer Foundation was utilized to develop and 
implement an intervention program based on the six-step 
process developed by the Quality Enhancement Research 
Initiative (QUERI) of the Department of Veteran Affairs (VA) 
was received.[16] The program integrated public health services 
provided by the county health department (Southern Nevada 
Health District [SNHD]) with clinical care for HIV-infected 
pregnant women and HIV-exposed infant provided by a county 
hospital and the medical school, with a focus to reduce or 
eliminate mother-to-child transmission (MTCT) of HIV. This 
report summarizes the process and outcome of the integrated 
program. The institutional review boards of University of 
Nevada, Reno and the University Medical Center of Southern 
Nevada (UMC) approved this project.
Subjects and Methods
Subjects
Approximately 72% of the population in Nevada and 87% of 
people infected with HIV live in Clark County.[17] The Wellness 
Center at the UMC provides medical care to the majority 
of adults with HIV including women in Clark County. The 
Nevada Care Program at the University of Nevada School of 
Medicine (UNSOM) provides care to pregnant women and 
HIV-exposed and infected children in Clark County. The SNHD 
provides surveillance and case management for HIV-infected 
persons and Aid for AIDS of Nevada provides social services 
for individuals infected with HIV in Clark County.
Methods
The method was based on the principles of implementation 
science developed in 1998 by the VA QUERI and 
community-based participatory research.[16] The six-step 
approach includes: (a) identify a high burden clinical issue 
(b) identify evidence-based clinical practice guidelines 
(c) define existing practices and identify performance gaps 
(d) develop and implement an intervention (e) evaluate system 
improvement (f) evaluate health outcomes and disseminate 
findings.
Identify a high burden clinic issue
The confidential name‑based HIV reporting system that was 
established in 1992 and is maintained by the SNHD was 
reviewed to identify HIV-infected women of childbearing 
age. Data were extracted on women who delivered an 
infant between July 2005 and June 2006, and their prenatal 
and hospital delivery records were reviewed. The medical 
records of HIV-exposed infants maintained by the UNSOM 
Department of Pediatrics were also reviewed. Data and medical 
record reviews were performed by a pediatric infectious disease 
specialist with expertise in the care of patients with HIV, who 
was assisted by a trained program coordinator.
Identify evidence‑based clinical practice guidelines
The medical literature was reviewed to identify current 
evidence-based guidelines and recommendation in 2006, 
to reduce MTCT including those from the CDC, American 
College of Gynecologist, AAP; United States Preventive 
Services Task Force (USPSTF) and the Institute of 
Medicine (IOM).[18-21] All of the above agencies identified 
routine prenatal HIV testing as a rate-limiting step toward 
prevention of mother-to-child HIV transmission (PMTCT) and 
lack of corrdination of care as creating missed opportunities 
for preventing MTCT. HIV-infected pregnant women 
identified early in pregnancy who are able to be enrolled in 
prenatal care and have access to available ARV therapy are 
shown to reduce significantly the risk of HIV transmission. 
HIV‑infected pregnant women identified during labor are still 
able to reduce the risk of transmission to <10% when they 
receive ARV therapy during labor, and prophylactic ARV 
therapy is administered to their HIV-exposed infant.
Define existing practices and identify performance gaps
Detailed review of cases where MTCT occurred was 
performed to identify performance gaps based on six main 
variables: (1) adequacy of prenatal care (2) HIV diagnoses 
of expectant mothers prior to delivery (3) appropriate use of 
ARV therapy before delivery (4) appropriate use of cesarean 
section for delivery (5) adequacy of zidovudine prophylaxis 
to newborn (6) HIV transmission rate.
In 2005–2006, pregnant women in Nevada were only 
screened for HIV if they were identified as “high risk” by 
their obstetricians. Only one hospital in Clark County had 
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a well‑defined protocol for screening pregnant women who 
presented in labor with unknown HIV status. Only one center 
provided comprehensive care for HIV-infected pregnant 
women in Clark County with a population of 1.9 million in 
2006. SNHD maintains data on individuals with HIV/AIDS, 
but there were no systematic methods for the hospitals, 
obstetricians, and pediatricians to confirm the HIV status of 
pregnant women to allow for early intervention. No pediatric 
program was dedicated to the follow-up of infants who had 
been perinatally exposed to HIV, and there was no defined 
communication between the SNHD, the obstetricians and 
pediatrician providing surveillance, or prenatal and pediatric 
care.
Design an intervention and define outcome measures
Information obtained from our review of performance gaps 
was used to design a program to address identified barriers. 
Five community organizations were invited to partner with 
the UNSOM in developing an intervention program that 
would integrate services provided by SNHD and community 
organizations with clinical services provided by the UNSOM 
Departments of Pediatrics and Obstetrics. Each agency 
was assigned specific roles [Figure 1]. A 7-step integrated 
intervention for the care of HIV-infected pregnant women and 
HIV-exposed infants was developed [Table 1]. For the purpose 
of this study and in order for consistency in evaluating pre- and 
post‑intervention outcomes, certain terms were defined as 
follows: (a) adequate prenatal care was defined as cases where 
a pregnant woman with HIV had at least two prenatal visits 
prior to delivery; (b) HIV-infected pregnant women were 
considered to have received appropriate ARV therapy during 
pregnancy if the combination ARV therapy prescribed was 
“preferred” in USPSTF’s recommendations for HIV treatment 
were instituted prior to labor; (c) appropriate use of cesarean 
section for delivery was defined as cesarean section delivery 
for a HIV-infected pregnant woman with the most recent viral 
load prior to labor above 1000 copies/ml or for other medical 
reasons including previous cesarean section; (d) adequacy of 
zidovudine prophylaxis to newborn was defined as initiation of 
zidovudine within 12 h of birth and completion of prophylaxis 
for a 6 weeks following birth; (e) a child was defined to be 
































Figure 1: (a) Southern Nevada Health District, (b) University Medical Center of Southern Nevada Wellness Center, (c) Area Health Education 
Center, (e) Aid for AIDS of Nevada, (f) University of Nevada School of Medicine
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pro-viral particle by qualitative HIV DNA polymerase chain 
reaction on two separate specimens and HIV negative if he/she 
had two negative HIV test obtained at or after 1-month.
Evaluate system improvement
Six predefined outcome measure were used to evaluate system 
improvement after 6 years (2007–2012).
• adequacy of prenatal care
• HIV diagnoses of expectant mothers prior to delivery
• appropriate use of ARV therapy before delivery
• appropriate use of cesarean section for delivery
• adequacy of zidovudine prophylaxis to newborn
• HIV transmission rate.
Evaluate health outcomes and disseminate findings
Final HIV sero-status of the infant using appropriate diagnostic 
test for exposed infants was used to evaluate and define health 
outcomes and health-related quality of life. All descriptive 




A review of the database for HIV infection maintained by 
the SNHD revealed that the final HIV status of all infants 
born between 2000 and 2004 were indeterminate due to 
“loss to follow‑up” that did not allow a final HIV status 
to be established. In 2005, there were 5406 persons living 
with HIV/AIDS in Clark County, 495 (9%) were women of 
childbearing age. Twenty-six infants were born to women with 
HIV between September 2005 and June 2006. One hundred and 
five infants were born to women with HIV from 2007 to 2012. 
Demographic information is provided in Table 2. Of the 
HIV-positive women, 69% had Medicaid, 5% were uninsured 
and 27% had private health insurance.
Prior to 2007, only one hospital implemented a rapid HIV 
testing during labor for women presenting in labor with 
unknown HIV sero-status. At the end of 2012, all ten local 
hospitals in Clark County with a labor and delivery unit had a 
protocol for rapid HIV testing for women presenting in labor 
with unknown HIV sero-status.
Evaluate system improvement
We evaluated improvements in the six predefined outcome 
measure after 6 years.
Among the 26 HIV-infected women who delivered prior to 
the implementation of the integrated program, 58% (15/26) 
had adequate prenatal care. Among women who delivered 
Table 2: Demographic characteristics of mothers: Pre‑ and post intervention
Exposed infants Sex Race/ethnicity
Year of birth Number 
of births
Males Females African 
American






2005* 5 2 3 2 2 0 0 0 1
2006** 21 13 8 9 8 4 0 0 0
Total 26 15 11 11 10 4 0 0 1
Post‑intervention
2007 20 10 10 11 4 4 0 0 1
2008 19 7 12 10 3 4 1 1 0
2009 22 10 12 10 8 2 0 0 2
2010 24 8 16 13 5 5 0 0 1
2011 10 6 4 7 1 1 0 0 1
2012 10 4 6 7 1 1 0 0 1
Total 105 45 60 58 22 17 1 1 6
*Pre-intervention data collection began September 2005, **Pre-intervention ended June 2006
Table 1: Seven‑step approach to care of HIV‑infected 
pregnant women and HIV‑exposed infants
Positive HIV tests are reported to the Clark County Health 
Department from all laboratories and physician practices as 
mandated by state law
Health Department Surveillance team reaches out to contact 
patient, and if confirmed pregnant, brings it to the attention of the 
maternal‑child HIV team
Pregnant woman is assisted in enrolling into care at the wellness 
center under the care of an adult HIV specialist and an obstetrician. 
Patients are also assisted in identifying other care providers and 
obstetricians not within the county hospital system if they so desire
Pregnant women are scheduled to meet with pediatrician to discuss 
expected plan of care for their infant once he/she is delivered. 
Education is provided with regards to risk of transmission and 
available interventions to reduce risk of transmission
Social support is provided through the health department and AFAN 
including but not limited to transportation and housing as needed
All pregnant women presenting in labor at all hospitals in Las 
Vegas were assessed for documented HIV sero‑status. Rapid HIV 
testing is performed on all pregnant women with unknown HIV 
sero‑status unless patient declines
Patients are discussed during a monthly clinical meeting where 
barriers to care are assessed, identified and a specific plan was 
developed to eliminate or reduce barrier
AFAN: Aid for AIDS of Nevada
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following the implementation of the integrated intervention, 
85% (89/105) had adequate prenatal care. Preintervention, 
46% (12/26) of HIV-positive mothers were diagnosed prior 
to pregnancy, 35% (9/26) during pregnancy, 4% (1/26) during 
labor and 15% after delivery. Postintervention, 63% (66/105) 
of HIV-positive mothers were diagnosed prior to pregnancy, 
31% (33/105) during pregnancy, 5% (5/105) during labor and 
1% (1/105) after delivery.
Lack of appropriate screening during pregnancy, labor and 
delivery led to missed opportunities to initiate ARV therapy to 
pregnant women. Of the 26 HIV-positive women who delivered 
from September 2005 to June 2006, 62% (16/26) received 
appropriate ARV therapy during pregnancy, and 73% (19/26) 
received ARV therapy during labor. Postintervention, 
81% (85/105) of the HIV-positive women, received ARV 
therapy during pregnancy, and 86% (90/105) received ARV 
therapy during labor.
Preintervention, 62% (16/26) of HIV-infected pregnant received 
appropriate delivery by cesarean section. Postintervention, 
cesarean sections were performed on 74% (78/105) of the 
HIV-infected mother and all (100%) were judged to be medical 
appropriate. We made this determination by reviewing our 
cesarean section cases and found that the majority of cases 
were due to the history of previous cesarean and request by 
the pregnant women for repeat cesarean section. Cesarean 
sections were not related to persistent lack of viral suppression.
Only 69% (18/26) of the 26 infants born from September 
2005 to June 2006 received adequate zidovudine prophylaxis 
defined as initiation of zidovudine within 12 h of birth 
and 54% (14/26) had documented completion of 6 weeks 
therapy with zidovudine. Postintervention, 87% (91/105) of 
HIV-exposed infants, received zidovudine within 12 h of birth, 
and 87% (91/105) had documented completion of 6 weeks 
therapy with zidovudine.
Six infants were documented to have been infected with HIV 
among the 26 infants delivered during the preintervention 
period September 2005 through June 2006. No MTCT was 
documented among the 105 infants born postintervention 
from 2007 to 2012.
Discussion
The World Health Organization in its recent publication of 
PMTCT strategic vision 2010–2015 outlined that “priority will 
be given to strengthening linkages between PMTCT and HIV 
care and treatment services for women, their children, and other 
family members in order to support an effective continuum of 
care.”[22] Such an integrated approach between public health 
departments, primary care practices and hospitals, provides 
support to women who are known to be HIV-infected or test 
positive for HIV during pregnancy and is also in line with the 
World Health Organization and the IOM’s recommendations.[22,23] 
The result from our program validates the point that MTCT of 
HIV can be eliminated when an integrated approach to the care 
of HIV-infected women and exposed newborns is implemented.
Although women accounted for an estimated 8% of HIV/AIDS 
infected adults in 1985, that proportion had increased steadily 
to an estimated 25% of new infections in 2006, with a majority 
of infections occurring among women of childbearing 
age.[24] Studies evaluating missed opportunities to prevent 
perinatal HIV transmission in the United States conducted 
between 1996–2000 and 2005–2008 noted that the majority 
of HIV-infected pregnant women had one or more missed 
opportunities to prevent perinatal HIV transmission.[25]
In response to the six cases of perinatal HIV-infection 
in newborns in 2005–2006, we began the process of 
implementing the comprehensive HIV program in Clark 
County. To obtain buy in from the community hospitals, we 
formed the community advisory board for the elimination 
of pediatric HIV. The advisory board was comprised of staff 
representatives from pediatric and adult HIV clinics, nursing 
case managers from the county Health Department and hospital 
representatives from the 10 local hospitals that had a delivery 
unit. This committee met once a month and reviewed the 
national HIV perinatal guideline to produce a local version 
that detailed the management of women who present in labor 
with known and unknown HIV status and their infants. These 
hospital representatives, who were in most cases nurses and 
directors of their hospital delivery units, were critical to the 
success of our program. They acted as liaisons between the 
hospitals and the SNHD. They were the contact person to 
verify the HIV status of women presenting in labor through the 
county name‑based database. The privacy and confidentiality 
requirement was maintained through existing memorandum 
between the hospitals and the health department.
Once the local guidelines were approved by the hospitals, we 
embarked on a 6 months training session where in-service 
trainings were conducted in all the hospitals. Each hospital 
had four training sessions organized in such a manner that it 
occurred during the morning and evening hand-over session 
and included the nursing and laboratory staff. This allowed 
the team the opportunity to reach most of the nursing and 
laboratory staff including those on day and night shifts. The 
training curriculum included appropriate test requisitions, 
rapid HIV testing by the laboratory team, a protocol for 
the management of the HIV-exposed infant including the 
appropriate blood specimen for testing.
The program team met once a month with the nursing case 
management team from the health department. Under an 
existing memorandum of understanding, we discussed each new 
HIV case documented in a pregnant woman. We also reviewed 
the care of existing pregnant women who were in care to identify 
barriers to care especially social issues that included but were 
not limited to transportation and housing during pregnancy. We 
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discussed postpartum follow-up and discharge of infants from 
the program to their regular pediatricians once HIV infection 
had been ruled out. A result of the work of the program team was 
mandatory HIV screening for all pregnant women, which was 
implemented in Nevada following the passage of Nevada Senate 
Bill 266. This bill was passed in 2007 and was instrumental for 
enhanced identification of HIV‑infected women who became 
pregnant.[26] The comprehensive nature of this intervention and 
the taskforce approach was instrumental to reducing the missed 
opportunities for PMTCT in our community.
After the integrated intervention, women who were identified 
early in their pregnancy had multiple opportunities to 
be brought into care. The integrated approach provided 
coordination and collaboration where prenatal care was 
provided by an obstetrician. In addition, they meet at least 
once with the pediatric infectious diseases physician during 
pregnancy to discuss factors that affected the risk of perinatal 
transmission and to develop a plan of care once the infant was 
delivered. Our report shows that such initial contact with a 
pediatrician led to increased compliance with follow-up of the 
infant and compliance with postnatal zidovudine prophylaxis. 
Approximately 69% of our patient had some form of public 
sponsored insurance which presented an initial challenge to 
enrollment into prenatal care, but ultimately removed cost as 
a barrier to prenatal care attendance.
Our report shows that lack of prenatal screening for HIV 
during pregnancy and labor increased the risk that HIV-infected 
women were not identified in time and opportunities for 
initiating zidovudine prophylaxis were missed. The lack of a 
coordinated program led to poor follow-up of HIV-exposed 
infants and adherence to zidovudine prophylaxis during the 
preintervention period which improved dramatically to 87% 
postintervention. We believe that early involvement of a 
pediatrician can tremendously improve follow-up after delivery 
as relationship are established early, and a clear follow-up plan 
is developed. This analysis showed that all cases of perinatal 
transmission in the preimplementation period of the integrated 
program were among minority women (25% Hispanics and 
75% African American) who had limited or no prenatal care. 
This is consistent with recent results in the US that showed 
that during 2007–2009, 85% of diagnoses of perinatal 
HIV-infection were in Blacks (63%) or Hispanics (22%).[27] 
Overall, while the proportion of women with HIV infection 
has risen in the US, the number of reported cases of perinatal 
transmission has declined from an estimated annual peak of 
1650 infected infants in mid-1990s to 162 infants in 2010.[27] 
Our finding of no cases of perinatal transmission diagnosed 
postimplementation is consistent with other studies that 
showed reductions in perinatal transmission with successful 
implementation of strategies aimed at identifying HIV-infected 
pregnant women before or early in pregnancy, treating 
HIV-infection in pregnant women with highly active ARV 
therapy, zidovudine prophylaxis during labor and delivery, and 
zidovudine prophylaxis to HIV-exposed infants.[10]
Limitations
Our analysis has a number of limitations. First, it is a single 
site experience, and even though it included all deliveries 
in the county, our experience may be different from other 
part of the country. Second, care for HIV-infected adults and 
children were concentrated in two major medical centers in 
our community, and it was easier to implement an integrated 
program. It may be more difficult to implement in communities 
without consolidated HIV care centers. Thirdly, successful 
passage of the Nevada Senate Bill mandating HIV screening 
of all pregnant women in our community could have made 
our educational and outreach interventions more successful by 
allowing for increased communication between obstetricians 
and pediatricians and greater collaboration among HIV service 
organization, hospitals and the health district.
Conclusion
Our study indicated that an integrated approach to the care of 
pregnant HIV-infected women and their newborns can led to a 
reduction in missed opportunities for prevention and eventual 
eradication of perinatal HIV transmission by increasing the 
odds that the women and their newborns receive recommended 
interventions.
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